Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2025-12-25 @ 4:06 AM
NCT ID:
NCT02845102
Eligibility Criteria:
Inclusion Criteria:
The study intervention will include both men and women admitted to Boston Medical Center in the last 24 hours. The study investigators will enroll those who are:
1. over 18 years old,
2. and/or admitted to the general medical or cardiology service of BMC with primary diagnosis of CHF or COPD exacerbation
3. and/or patients of ambulatory care clinics, specialty care clinics and/or chronic pain groups of BMC Family Medicine Health Centers
4. and/ or patients of Behavioral Health in the Department of Family Medicine and/or BMC Family Medicine Health Centers
5. and/or participants recruited from BU/BMC ecommunications and community settings such as community centers, recreational centers, senior centers, and weight loss centers.
6. and/or have ever been diagnosed with any symptoms of chronic illness such as Chronic Heart Failure (CHF) and/or Chronic Obstructive Pulmonary Disease
7. speak English with health providers,
8. have access to a telephone
9. have permanent housing and/or are not housed within shelter programs
10. Live in the Boston area, and do not plan on leaving the Boston area for more than 2 weeks in the next 6 months
11. are able to independently consent. If patients meet these criteria, the PHQ-2 will be administered during feasibility screening. Those who score ≥3 on the PHQ-2 during this pre-consent screening and will be consented. The PHQ-2 score will carry over into post-consent screening of the feasibility testing enrollment form.
The PHQ-8 will be administered post-consent during the enrollment process. Those who score ≥5 on the PHQ-8 and meet the other post-consent screening on the enrollment form will be enrolled in the study.
Exclusion Criteria:
* Using clear protocols, the study investigators will identify those who do not have indications for CBT amd will exclude:
1. Under 18 years of age
2. Unable to speak English with health providers
3. Those who do not have indications for CBT (e.g., active substance abuse, dementia, bipolar disease, schizophrenia, psychotic symptoms, prior history of ECT, among others based on Mini International Neuropsychiatric Inventory).
4. Those who are suicidal or homicidal,
5. Those who are currently in police custody and/or incarcerated,
6. Those who do not live in the Boston (or MA) area, or those who plan on leaving the Boston area for more than 2 weeks in the next 6 months.
7. If they do not live in permanent housing and/or live in shelter programs,
8. Those who are already engaged in psychotherapy
9. Those who are currently pregnant or planning to become pregnant during the course of the study
10. Those who are receiving current treatment for active cancer diagnosis or who have been diagnosed with sickle cell anemia.
11. The study investigators will not approach those patients who are on neurosurgery, hematology/ oncology, and/or trauma service.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02845102
Study Brief:
Protocol Section:
NCT02845102